Viome nutrition program for IBS symptoms
Part of Digestive system clinical trials.
This trial studies whether a Viome nutrition program (based on supplement/formulation instructions) can improve symptoms in people with IBS. You may be asked to follow a specific nutrition plan and tracking steps for the study period.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Live in the United States
- Be age 25 to 75 and able to read and speak English
- Have IBS diagnosed using ROME IV criteria and an IBS symptom score between 125 and 450
- Have no unexplained weight loss, fevers, anemia, or blood in your stool
- Be able and willing to follow the study instructions, including using the Viome app on an iPhone or Android
- Agree not to change your current diet for the trial and not use Viome products before starting
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a personalized Viome nutrition program can improve metabolic health (such as higher fasting insulin or glucose). You would use their app and follow the program, while researchers monitor health outcomes over time.
This trial tests whether Viome's personalized nutrition program helps lower blood sugar (A1c) in people with type 2 diabetes. You will get a diet plan tailored to you and use an app to track your progress.
This trial studies whether a specific diet plan delivered through a phone app (the DOMINO diet) can improve symptoms in people with irritable bowel syndrome (IBS). It may help by changing what you eat to reduce gut symptoms, compared with standard care rules in the study.
This trial tests a personalized low-FODMAP diet plan, a diet that avoids certain carbohydrates that can trigger gut symptoms, using a mobile app to help manage IBS. It aims to see if this approach improves symptoms and how it affects the connection between your gut and your brain.
This trial tests whether a synbiotic (a mix of probiotics and prebiotics) called Vivatlac can improve gut health in people with moderate to severe irritable bowel syndrome (IBS). If you have IBS and are not already taking probiotics or antibiotics, you may be able to join.
This study tests a daily supplement containing beneficial bacteria (synbiotic) and plant extracts to improve gut health and reduce symptoms of irritable bowel syndrome (IBS), such as bloating, gas, and changes in bowel habits. It lasts about 16 weeks and involves taking the supplement and providing blood and stool samples.
Hear when a new Gastrointestinal Health trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.